In August 2024, Eli Lilly & Company announced the positive outcomes of the SURMOUNT-1 trial, indicating that Tirzepatide (marketed as Zepbound and Mounjaro) decreased the risk of developing type 2 diabetes by 94% in individuals with prediabetes, obesity, or overweight
Unfortunately, by the age of thirty, the bodys natural production of Glutathione begins to decline just as exposure to environmental toxins, stress, and pollutants continues to rise
As our skin is the bodys first line of defense, it is often the first to show signs of aging like dullness, wrinkles, and pigmentation
BPC-157 features in peptide-mediated signalling and cellular-response studies, while TB-500 is commonly investigated in relation to actin dynamics and cytoskeletal organisation